GreenLight Biosciences
-
Ticker
GRNA
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Medford, Massachusetts
GreenLight Biosciences aims to address some of the world’s biggest problems by delivering on the full potential of RNA for human health and agriculture. Their RNA platform allows them to research, design, and manufacture for human, animal, and plant health. In human health, this includes messenger RNA vaccines and therapeutics. In agriculture, this includes RNA to protect honeybees and
…More a range of crops. The Company’s platform is protected by numerous patents. GreenLight’s human health product candidates are in the pre-clinical stage, and its product candidates for the agriculture market are in the early stages of development or regulatory review. GreenLight is a public benefit corporation that trades under the ticker GRNA on Nasdaq.
GreenLight Biosciences
Most Recent Responsibility Report
MOST RECENT
2022 Sustainability Report
Report Locked. GreenLight Biosciences has reached its limit for free report views.
Our service enables potential investors to review the most recent and archived GreenLight Biosciences Sustainability Report, GreenLight Biosciences Corporate Social Responsibility Report, GreenLight Biosciences CSR Report, GreenLight Biosciences Corporate Responsibility, GreenLight Biosciences CR Report, GreenLight Biosciences Citizenship Report, GreenLight Biosciences ESG Report, and GreenLight Biosciences Environmental Report online.